The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Aerovate Therapeutics Inc(NASDAQ:AVTE)


Aerovate Therapeutics is a clinical stage biopharmaceutical company whose mission is to advance novel therapeutics and to help people with rare cardiopulmonary diseases gain control over their health, and their lives.
Website: https://www.aerovatetx.com/
Founded: 2018
IPO Price: $14 (Jun 29, 2021)
CEO: Tim Noyes
Sector:
Industry:
Aerovate Therapeutics Number of Twitter Followers
Aerovate Therapeutics Days Payable Outstanding ttm (DPO)
Aerovate Therapeutics Op Cashflow Per Share ttm
Aerovate Therapeutics Free Cashflow Per Share ttm
Aerovate Therapeutics Cash Per Share ttm
Aerovate Therapeutics (GAAP) P/E ratio ttm
Aerovate Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.